HR7237-119

In Committee

Chemical Abortion Risk Awareness Act

119th Congress Introduced Jan 23, 2026

Analysis under review: This bill has generated analysis that may be too generic or incomplete. Clause-level evidence remains available below.

Summary

What This Bill Does

Note: Full bill text is not yet available for analysis. The following is based solely on the bill title.

Amends the Public Health Service Act regarding requirements for women seeking chemical abortion, potentially adding informed consent or safety requirements.

Full title: To amend the Public Health Service Act to ensure that a woman seeking a chemical abortion is made aware of the risks involved, and for other purposes.

Analysis Status

This summary is based on the bill title only. A complete analysis will be available once the full bill text is published and ingested into our system.

Expected Policy Domains

Based on the title, this bill likely relates to: Healthcare, Pharmaceuticals

Evidence Chain:

This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers.

At a Glance

What This Bill Does

[TEXT NOT YET AVAILABLE] Based on title: Amends the Public Health Service Act regarding requirements for women seeking chemical abortion, potentially adding informed consent or safety requirements.

Key Policy Areas

Healthcare, Pharmaceuticals

Primary Purpose

[TEXT NOT YET AVAILABLE] Based on title: Amends the Public Health Service Act regarding requirements for women seeking chemical abortion, potentially adding informed consent or safety requirements.

Policy Domains

Healthcare Pharmaceuticals

Bill Text Pending

Identified Gains
Contextual inference, no direct clause citation
  • [Cannot determine without full bill text]
Model: claude-opus-4-5-20251101 | Version: bill_summary_v2 | Source: N/A

Contextual inference, no direct clause citation

Identified Costs
Contextual inference, no direct clause citation
  • [Cannot determine without full bill text]
Model: claude-opus-4-5-20251101 | Version: bill_summary_v2 | Source: N/A

Contextual inference, no direct clause citation

Legislative Progress

In Committee
Introduced Committee Passed
Jan 23, 2026

Referred to the House Committee on Energy and Commerce.

Jan 23, 2026

Introduced in House

Jan 23, 2026

Mr. Stutzman (for himself and Mrs. Harshbarger) introduced the following …

Impact analysis is available but no clear stakeholder effects identified. View clause-level analysis →

Bill Structure & Actor Mappings

Who is "The Secretary" in each section?

Domains
Healthcare Pharmaceuticals

We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.

Learn more about our methodology